Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor β-gene

被引：0
|
作者：
Bastie, JN
Garcia, I
Terré, C
Cross, NCP
Mahon, FX
Castaigne, S
机构：
[1] Salisbury Dist Hosp, Dept Hematol & Oncol, Salisbury, Wilts, England
[2] Salisbury Dist Hosp, Dept Biochem Haematol & Cytogenet, Salisbury, Wilts, England
[3] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England
[4] Univ Bordeaux 2, CNRS, Unite 2617, F-33076 Bordeaux, France
来源：
HAEMATOLOGICA | 2004年 / 89卷 / 10期
关键词：
atypical chronic myeloproliferative disorder; PDGFRB; t(5; 10); imatinib mesylate;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Imatinib mesylate has been reported to produce positive results in atypical chronic myeloproliferative disorders (CMD) with chromosomal translocations that disrupt the platelet-derived growth factor receptor (3 gene (PDGFRB). We used imatinib to treat a 49-year old man with atypical CMD in accelerated phase and the H4 (D10S170)-PDGFRB fusion gene. After 3 months of treatment, we observed grade 4 hematologic toxicity and a lack of response.
引用
收藏
页码：1263 / 1264
页数：2
相关论文
共 50 条
  • [1] Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
    Apperley, JF
    Gardembas, M
    Melo, JV
    Russell-Jones, R
    Bain, BJ
    Baxter, J
    Chase, A
    Chessells, JM
    Colombat, M
    Dearden, CE
    Dimitrijevic, S
    Mahon, FX
    Marin, D
    Nikolova, Z
    Olavarria, E
    Silberman, S
    Schultheis, B
    Cross, NCP
    Goldman, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07): : 481 - 487
  • [2] Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia
    Yoshimitsu Shimomura
    Hayato Maruoka
    Takayuki Ishikawa
    International Journal of Hematology, 2017, 105 : 697 - 701
  • [3] Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia
    Shimomura, Yoshimitsu
    Maruoka, Hayato
    Ishikawa, Takayuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (05) : 697 - 701
  • [4] Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer
    Mathew, P
    Fidler, IJ
    Logothetis, CJ
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 24 - 29
  • [5] Philadelphia Chromosome-Negative Myeloproliferative Neoplasm With a Novel Platelet-Derived Growth Factor Receptor-β Rearrangement Responsive to Imatinib
    Cornfield, Dennis
    Shah, Usman
    Cross, Nicholas
    Bennett, Courtney
    Sun, Guoxian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) : E109 - E111
  • [6] Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor
    Holdhoff, M
    Kreuzer, KA
    Appelt, C
    Scholz, R
    Na, IK
    Hildebrandt, B
    Riess, H
    Jordan, A
    Schmidt, CA
    Van Etten, RA
    Dörken, B
    le Coutre, P
    BLOOD CELLS MOLECULES AND DISEASES, 2005, 34 (02) : 181 - 185
  • [7] Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
    Kubo, Tadahiko
    Piperdi, Sajida
    Rosenblum, Jeremy
    Antonescu, Cristina R.
    Chen, Wen
    Kim, Han-Soo
    Huvos, Andrew G.
    Sowers, Rebecca
    Meyers, Paul A.
    Healey, John H.
    Gorlick, Richard
    CANCER, 2008, 112 (10) : 2119 - 2129
  • [8] Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans
    Rubin, BP
    Schuetze, SM
    Eary, JF
    Norwood, TH
    Mirza, S
    Conrad, EU
    Bruckner, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3586 - 3591
  • [9] Receptor tyrosine kinases as rational targets for prostate cancer treatment: Platelet-derived growth factor receptor and imatinib mesylate
    George, DJ
    UROLOGY, 2002, 60 (3A) : 115 - 121
  • [10] Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis
    Haroche, Julien
    Amoura, Zahir
    Charlotte, Frederic
    Salvatierra, Juan
    Wechsler, Bertrand
    Graux, Carlos
    Brousse, Nicole
    Piette, Jean-Charles
    BLOOD, 2008, 111 (11) : 5413 - 5415
12345